Study ID | Study design | Location | Device tested | Standard compared against | Sampling strategy | Blinded measurement and recording | Pattern of BP measurements | Interval between BP measurements | Appropriate statistical analysis | Source of funding |
---|---|---|---|---|---|---|---|---|---|---|
Li et al25 | Observational | Dangxiong County, Lhasa | Omron HEM-759P | Mercury sphygmomanometer | Convenience sampling | Yes | 3 consecutive measurements | 1 min | Yes | Bureau of Science and Technology of Tibet, the US National Heart, Lung, and Blood Institute, and the UnitedHealth Chronic Disease Initiative |
Cho et al26 | Observational | Linzhou County, Lhasa | Omron HEM-7201 | Mercury sphygmomanometer | Not reported | Yes | 9–10 consecutive measurements alternating between the automated and mercury sphygmomanometer | 30 s to 1 min | Yes | The US National Heart, Lung, and Blood Institute (National Institutes of Health) and the UnitedHealth Chronic Disease Initiative |
BP, blood pressure.